Nephronomics: StrategicDevelops AI-driven precision medicine for cardio-kidney-metabolic diseaseOct 4, 2026RoundOSNephronomicsCompany profile and funding historySourcesprnewswire.comMore in HealthtechMetriport · Series AProFound Therapeutics · StrategicArintra · Series BAIBiotechUnited StatesEnterprise softwareHealthtechNorth AmericaUndisclosed